STAAR Surgical (STAA) director awarded RSUs and exercises prior units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

STAAR Surgical director Lou Silverman reported compensation-related equity activity. He exercised 10,683 previously granted restricted stock units into an equal number of common shares and now directly holds 11,158 shares. On the same date, he received a new grant of 6,182 restricted stock units for the 2026–2027 non‑employee director term, which will vest in full on the earlier of June 18, 2027 or the company’s 2027 annual shareholder meeting. All transactions reflect equity awards and exercises rather than open‑market buying or selling.

Insider Trade Summary

10,683 shares exercised/converted

Mixed 3 txns

Insider SILVERMAN LOU

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	10,683	$0.00	--
Grant/Award	Restricted Stock Units	6,182	$0.00	--
Exercise	Common Stock	10,683	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 11,158 shares (Direct, null)

Footnotes (1)

Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

Key Figures

RSUs exercised into common stock: 10,683 shares New RSU grant: 6,182 units Common shares held after transactions: 11,158 shares +2 more

5 metrics

RSUs exercised into common stock 10,683 shares Restricted stock units converted to common stock on June 18, 2026

New RSU grant 6,182 units Director equity award for 2026–2027 term granted June 18, 2026

Common shares held after transactions 11,158 shares Direct ownership reported following June 18, 2026 transactions

Underlying common shares for new RSUs 6,182 shares Each restricted stock unit is linked to one common share

Transaction count 3 transactions One common stock entry and two RSU entries reported on Form 4

Key Terms

Restricted Stock Units, annual non-employee director equity compensation program, vested, Annual Meeting of Shareholders

4 terms

Restricted Stock Units financial

"Reflects restricted stock units granted to the Reporting Person on June 18, 2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

annual non-employee director equity compensation program financial

"pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term"

vested financial

"which vested on June 18, 2026"

Annual Meeting of Shareholders regulatory

"on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/22/2026 - 04:05 PM Accepted by SEC EDGAR 06/22/2026 - 04:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SILVERMAN LOU

(Last)

(First)

(Middle)

25510 COMMERCENTRE DRIVE

(Street)

LAKE FOREST

CALIFORNIA

92630

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock⁽¹⁾	06/18/2026		M		10,683	A	$0	11,158	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units⁽¹⁾	$0	06/18/2026		M			10,683	⁽¹⁾	⁽¹⁾	Common Stock	10,683	$0	0	D
Restricted Stock Units⁽²⁾	$0	06/18/2026		A		6,182		⁽²⁾	⁽²⁾	Common Stock	6,182	$0	6,182	D

Explanation of Responses:

1. Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.

2. Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

Remarks:

This Form 4 reflects the equity awards granted to the Reporting Person on June 18, 2026 pursuant to Issuer's annual non-employee director equity compensation program for the 2026-2027 term.

	/s/ Kathleen Determann as attorney-in-fact for Louis E. Siverman	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did STAAR Surgical (STAA) director Lou Silverman report?

Lou Silverman reported exercising 10,683 restricted stock units into common shares and receiving a new grant of 6,182 restricted stock units. These awards are part of STAAR Surgical’s non-employee director equity compensation programs for the 2025–2026 and 2026–2027 board terms.

Were Lou Silverman’s STAAR Surgical (STAA) transactions open-market buys or sells?

The reported transactions were not open-market buys or sells. They reflect the exercise of previously granted restricted stock units into 10,683 common shares and a new grant of 6,182 restricted stock units as director compensation, rather than discretionary trading in STAAR Surgical stock.

How many STAAR Surgical (STAA) shares does Lou Silverman hold after these transactions?

After these transactions, Lou Silverman directly holds 11,158 shares of STAAR Surgical common stock. He also holds 6,182 additional restricted stock units from a new director equity grant, which are scheduled to vest in full in 2027 under the company’s compensation program terms.

What new equity award did Lou Silverman receive from STAAR Surgical (STAA)?

Lou Silverman received 6,182 restricted stock units on June 18, 2026 under STAAR Surgical’s annual non-employee director equity compensation program for the 2026–2027 term. These units convert into common shares when they vest, providing equity-based compensation linked to future service.

When do Lou Silverman’s new STAAR Surgical (STAA) restricted stock units vest?

The 6,182 restricted stock units granted to Lou Silverman vest in full on the earlier of June 18, 2027 or STAAR Surgical’s 2027 Annual Meeting of Shareholders. Vesting is tied to his continued service during the 2026–2027 non-employee director term.

What prior STAAR Surgical (STAA) award did Lou Silverman exercise into shares?

He exercised 10,683 restricted stock units that had been granted on June 18, 2025 under STAAR Surgical’s 2025–2026 non-employee director program. Those units fully vested on June 18, 2026 and were converted into 10,683 shares of common stock as reported in the filing.